Where Pharmacy Strategy Meets Performance
The 340B program has become one of the most complex operational and financial programs in healthcare. Covered entities must balance compliance, pharmacy program performance, manufacturer restrictions, and patient access while maintaining program sustainability.
Axis Strategies provides executive-level advisory services to help healthcare organizations optimize 340B program performance, strengthen compliance frameworks, and identify revenue opportunities within existing pharmacy infrastructure.
Evaluate program structure, utilization rates, and capture opportunities across entity-owned and contract pharmacy environments.
Axis advises healthcare organizations on pharmacy strategies that align both entity-owned pharmacies and contract pharmacy networks with broader clinical, operational, and financial objectives.
We help organizations evaluate dispensing models, optimize pharmacy utilization, strengthen referral capture, and ensure pharmacy operations support long-term program sustainability.
Prepare organizations for HRSA audits, manufacturer reviews, and internal governance requirements.
Support healthcare leadership teams navigating evolving 340B policy, manufacturer restrictions, and long-term program sustainability.
Axis Strategies works with healthcare organizations across the country seeking executive-level pharmacy and 340B strategy support.
Start a Conversation